2-Substituted-16-ene-22-thia-1α, 25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs:: Synthesis, biological evaluation, and crystal structure

被引:46
|
作者
Shimizu, Masato [1 ]
Miyamoto, Yukiko [1 ]
Takaku, Hajime [1 ]
Matsuo, Mayumi [1 ,2 ]
Nakabayashi, Makoto [1 ]
Masuno, Hiroyuki
Udagawa, Nobuyuki [3 ]
DeLuca, Hector F. [4 ]
Ikura, Teikichi [5 ]
Ito, Nobutoshi [5 ]
机构
[1] Tokyo Med & Dent Univ, Sch Biomed Sci, Med Chem Lab, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan
[3] Matsumoto Dent Univ, Dept Biochem, Nagano 3990781, Japan
[4] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[5] Tokyo Med & Dent Univ, Sch Biomed Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1138510, Japan
关键词
16-ene-22-thia-19-norvitamin D; VDR-binding affinity; transcriptional activity; structure-activity relationships; crystal structure;
D O I
10.1016/j.bmc.2008.05.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, we have found that 16-ene-22-thia-26,27-dimethyl-19-norvitamin D(3) analogs 1a (n = 2, 3) are 20 times more active than the natural hormone 1a, 25-dihydroxyvitamin D3 in terms of transcriptional activity. To further investigate the effects of the A-ring modi. cation of 1a, b on the biological activity pro. le, novel 22-thia-19-norvitamin D analogs 2-11 bearing a hydroxyethoxy-, hydroxyethylidene- or methyl group at C-2 in combination with 20S- and 20R-isomers were prepared and tested for their in vitro biological activities. All of the synthesized analogs showed 0.5-140% of the activity of the natural hormone in binding to the vitamin D receptor (VDR). When compared with the transcriptional activity of C-2 or C- 20 isomeric pairs of the 22-thia analogs, the 20S- isomers 2-11a were more potent than the 20R- isomers 2, 3, 8-11b, and the 2 beta-hydroxyethoxy, 2E-hydroxyethylidene, and 2 alpha-methyl-2 beta-hydroxy-22-thia isomers showed higher potency than their corresponding counterparts. In particular, 3a exhibited an extremely higher level of potency (210-fold) than the natural hormone. To elucidate the action mode of superagonist 3a at the molecular level, we determined the crystal structures of the rat VDR-ligand-binding domain complexed with 3a or 3b in the presence of peptide containing a nuclear box motif (LxxLL) at 1.9-2.0 angstrom resolution. The crystal structures demonstrated that the 1 alpha-OH, 3 beta-OH, and 25-OH groups of the natural hormone and 3a were anchored by the same amino acid residues in the ligand-binding pocket, and the terminal OH moiety of the substituent at C-2 formed hydrogen bonds with Arg270 and a water molecule to create a tight water molecule network. Moreover, the methyl groups at C-26a and C-27a make additional contact with hydrophobic residues such as Leu223, Ala227, Val230, and Ala299. These hydrophilic and hydrophobic interactions in 3a may underlie the induction of superagonistic activity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6949 / 6964
页数:16
相关论文
共 44 条
  • [31] Efficient synthesis of 2-modified 1α,25-dihydroxy-19-norvitamin D3 with Julia Olefination:: High potency in induction of differentiation on HL-60 cells
    Ono, K
    Yoshida, A
    Saito, N
    Fujishima, T
    Honzawa, S
    Suhara, Y
    Kishimoto, S
    Sugiura, T
    Waku, K
    Takayama, H
    Kittaka, A
    JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (19): : 7407 - 7415
  • [32] A-ring hydroxymethyl 19-nor analogs of the natural hormone 1α,25-dihydroxyvitamin D3:: synthesis and preliminary biological evaluation
    Hatcher, MA
    Peleg, S
    Dolan, P
    Kensler, TW
    Sarjeant, A
    Posner, GH
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (12) : 3964 - 3976
  • [33] SYNTHESES AND BIOLOGICAL-ACTIVITIES OF SIDE-CHAIN SUBSTITUTED ANALOGS OF 1-ALPHA,25-DIHYDROXY-26,26,26,27,27,27-HEXAFLUOROVITAMIN-D3 (F6-1-ALPHA,25(OH)2D3)
    HAMMA, N
    SAITO, Y
    KATSUMATA, T
    NAGATA, A
    NISHIZAWA, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S230 - S230
  • [34] Synthesis and biological evaluation of a 3-positon epimer of 1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71)
    Hatakeyama, Susumi
    Nagashima, Satoshi
    Imai, Naoko
    Takahashi, Keisuke
    Ishihara, Jun
    Sugita, Atsuko
    Nihei, Takeshi
    Saito, Hitoshi
    Takahashi, Fumiaki
    Kubodera, Noboru
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 222 - 226
  • [35] Evaluation of C-2-substituted 19-nor-1α,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer
    Chen, T. C.
    Persons, K. S.
    Zheng, S.
    Mathieu, J.
    Holick, M. F.
    Lee, Y. F.
    Bao, B.
    Arai, M. A.
    Kittaka, A.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 717 - 720
  • [36] Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1α,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalciferol (Ro 25-6760), on a human colon cancer xenograft
    Evans, SRT
    Schwartz, AM
    Shchepotin, EI
    Uskokovic, M
    Shchepotin, IB
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2869 - 2876
  • [37] Synthesis and antitumor activity of 1,25(OH)2-23-ene-26,27F6-19-nor-20-cyclopropyl D3, Ro 27-0574.
    Uskokovic, MR
    Manchand, P
    Koike, M
    Koshizuka, K
    Kawabata, H
    Yang, R
    Taub, H
    Said, J
    Tsuruoka, N
    Koeffler, HP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U571 - +
  • [38] 1α,25(OH)2-3-Epi-Vitamin D3, a Natural Physiological Metabolite of Vitamin D3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor
    Molnar, Ferdinand
    Sigueeiro, Rita
    Sato, Yoshiteru
    Araujo, Clarisse
    Schuster, Inge
    Antony, Pierre
    Peluso, Jean
    Muller, Christian
    Mourino, Antonio
    Moras, Dino
    Rochel, Natacha
    PLOS ONE, 2011, 6 (03):
  • [40] The biological activities of 1α,25-dihydroxyvitamin D3 and its synthetic analog 1α,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-β estradiol and dependent on stage of differentiation
    Rao, LG
    Liu, LJF
    Rawlins, MR
    McBroom, RJ
    Murray, TM
    Reddy, GS
    Uskokovic, MR
    Rao, DS
    Sutherland, MK
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (03) : 242 - 248